Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01139125 · ClinicalTrials.gov registry record · NA
An Open Trial of Cysteamine Treatment in Schizophrenia
A NA study, sponsored by Augusta University.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT01139125 is a NA study that was terminated before completion, run by Augusta University. The registered enrollment target is 3 participants.
The verdict
NCT01139125, a NA study, was terminated before completion, sponsored by Augusta University.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the tolerability of the medication cysteamine bitartrate on schizophrenia patients and to evaluate the effect of the medication on the symptoms of schizophrenia.
Interventions
- DRUG (Cystagon) Cysteamine Bitartrate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2009-09 |
| Est. Completion | 2012-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01139125
The ClinicalTrials.gov registry entry for NCT01139125 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Augusta University, which has 106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which (Cystagon) Cysteamine Bitartrate is the first listed.
NCT01139125 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01139125 about?
NCT01139125 is a clinical study titled "An Open Trial of Cysteamine Treatment in Schizophrenia". The purpose of this study is to determine the tolerability of the medication cysteamine bitartrate on schizophrenia patients and to evaluate the effect of the medication on the symptoms of schizophrenia.
What is the current status of trial NCT01139125?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2009-09. Estimated completion is 2012-06.
What interventions are being tested in trial NCT01139125?
The interventions under investigation include: (Cystagon) Cysteamine Bitartrate (DRUG).
Who is sponsoring clinical trial NCT01139125?
This trial is sponsored by Augusta University, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.